Alexandre Louvet

Author PubWeight™ 36.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011 8.50
2 M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 2013 2.16
3 Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology 2014 2.05
4 Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA 2013 1.94
5 Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2010 1.83
6 Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 2010 1.82
7 Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis. J Hepatol 2011 1.73
8 Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009 1.67
9 Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS One 2009 1.25
10 Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. Glycobiology 2005 1.13
11 The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 2006 1.09
12 Comment on: "Management of alcohol dependence in patients with liver disease". CNS Drugs 2013 1.07
13 NOD2: a potential target for regulating liver injury. Lab Invest 2008 0.95
14 Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology 2009 0.92
15 Evaluation of amantadine in chronic hepatitis C: a meta-analysis. J Hepatol 2004 0.91
16 Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol 2011 0.89
17 Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm Bowel Dis 2009 0.86
18 Peroxisome proliferator-activated receptors in HBV-related infection. PPAR Res 2009 0.82
19 Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl 2007 0.81
20 Treatment of severe forms of alcoholic hepatitis: where are we going? J Gastroenterol Hepatol 2008 0.80
21 Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. Proteomics Clin Appl 2010 0.80
22 Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France. Hepatology 2009 0.79
23 Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation Study. Cardiovasc Intervent Radiol 2014 0.77
24 Liver fibrogenesis and genetic factors. Clin Res Hepatol Gastroenterol 2011 0.77
25 Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France. J Hepatol 2008 0.76
26 Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol 2017 0.75
27 Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin. J Hepatol 2011 0.75
28 [Therapeutic misadventure with acetaminophen in alcoholics]. Presse Med 2008 0.75
29 Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol 2017 0.75
30 [Acute recurrent pancreatitis in a composite CFTR heterozygote and Spink1 heterozygote patient]. Gastroenterol Clin Biol 2006 0.75